Muscle-Organ Crosstalk: The Emerging Roles of Myokines - PubMed
- ️Wed Jan 01 2020
Review
Muscle-Organ Crosstalk: The Emerging Roles of Myokines
Mai Charlotte Krogh Severinsen et al. Endocr Rev. 2020.
Erratum in
-
Corrigendum to: "Muscle-Organ Crosstalk: The Emerging Roles of Myokines".
[No authors listed] [No authors listed] Endocr Rev. 2021 Jan 28;42(1):97-99. doi: 10.1210/endrev/bnaa024. Endocr Rev. 2021. PMID: 33045039 Free PMC article. No abstract available.
Abstract
Physical activity decreases the risk of a network of diseases, and exercise may be prescribed as medicine for lifestyle-related disorders such as type 2 diabetes, dementia, cardiovascular diseases, and cancer. During the past couple of decades, it has been apparent that skeletal muscle works as an endocrine organ, which can produce and secrete hundreds of myokines that exert their effects in either autocrine, paracrine, or endocrine manners. Recent advances show that skeletal muscle produces myokines in response to exercise, which allow for crosstalk between the muscle and other organs, including brain, adipose tissue, bone, liver, gut, pancreas, vascular bed, and skin, as well as communication within the muscle itself. Although only few myokines have been allocated to a specific function in humans, it has been identified that the biological roles of myokines include effects on, for example, cognition, lipid and glucose metabolism, browning of white fat, bone formation, endothelial cell function, hypertrophy, skin structure, and tumor growth. This suggests that myokines may be useful biomarkers for monitoring exercise prescription for people with, for example, cancer, diabetes, or neurodegenerative diseases.
Keywords: cancer; cytokines; diabetes; exercise; metabolism; physical activity.
© Endocrine Society 2020.
Figures
![Graphical Abstract](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/f062c5ffcb66/bnaa016if0001.gif)
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/46fefbda04d4/bnaa016f0001.gif)
Musclin, LIF, IL-4, IL-6, IL-7, and IL-15 promote muscle hypertrophy. Myostatin inhibits muscle hypertrophy.
![Figure 2.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/6da985edd9af/bnaa016f0002.gif)
Cathepsin B and irisin cross the blood–brain barrier and stimulate BDNF production, which leads to hippocampal neurogenesis. IL-6 stimulates appetite. Abbreviations: BDNF, brain-derived neurotrophic factor.
![Figure 3.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/17875df6fc17/bnaa016f0003.gif)
IL-6 stimulates lipolysis decreases visceral fat mass. Irisin, meteorin-like, and IL-6 have a role in “browning” of white adipose tissue. IL-6 and BDNF stimulate AMPK activation. Abbreviations: AMPK, 5′-AMP-activated protein kinase; BDNF, brain-derived neurotrophic factor.
![Figure 4.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/0704614ad860/bnaa016f0004.gif)
Decorin, IL-6, IGF-1, and FGF-2 positively regulate bone formation. Abbreviations: FGF-2, fibroblast growth factor 2; IGF-1, insulin-like growth factor I.
![Figure 5.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/04ac202b5c25/bnaa016f0005.gif)
Angiogenin, osteoprotegerin, and IL-6 possess pancreatic β-cell protective actions against proinflammatory cytokines. IL-6 increases insulin secretion by inducing the expression of GLP-1 by the L cells of the intestine. Abbreviations: GLP-1, glucagon-like peptide 1.
![Figure 6.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/f288538a3265/bnaa016f0006.gif)
IL-6 has anti-inflammatory effects as it inhibits TNF production and stimulates the production of IL-1ra and IL-10. IL-6 stimulates cortisol production and thereby induces neutrocytosis and lymphopenia. Abbreviations: IL-1ra, IL-1 receptor antagonist; TNF, tumor necrosis factor.
![Figure 7.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342a/7288608/62ec66d50f0b/bnaa016f0007.gif)
Cathepsin B and irisin cross the blood–brain barrier and stimulate BDNF production and hippocampal neurogenesis. IL-6 stimulates appetite and lipolysis and decreases visceral fat mass. Irisin, meteorin-like, and IL-6 have a role in “browning” of white adipose tissue. IL-15 improves aging skin. Decorin, IL-6, IGF-1 and FGF-2 positively regulate bone formation. Myostatin negatively regulate bone formation. Musclin, LIF, IL-4, IL-6, IL-7, and IL-15 promote muscle hypertrophy. Myostatin inhibits muscle hypertrophy. BDNF and IL-6 are involved in AMPK-mediated fat oxidation. IL-6 enhances insulin-stimulated glucose uptake and stimulates glucose output from the liver, but only during exercise. IL-6 increases insulin secretion by inducing the expression of GLP-1 by the L cells of the intestine. IL-6 has anti-inflammatory effects as it inhibits TNF production and stimulates the production of IL-1ra and IL-10. IL-6 stimulates cortisol production and thereby induces neutrocytosis and lymphopenia. FSTL-1 improves endothelial function and revascularization of ischemic blood vessels. Angiogenin, osteoprotegerin and IL-6 possess pancreatic β-cell protective actions against proinflammatory cytokines. Abbreviations: AMPK, 5′-AMP-activated protein kinase; BDNF, brain-derived neurotrophic factor; FGF-2, fibroblast growth factor 2; FGF-21, fibroblast growth factor 21; FSTL-1, follistatin-related protein 1; GLP-1, glucagon-like peptide 1; IGF-1, insulin-like growth factor I; IL-1ra, IL-1 receptor antagonist; LIF, leukemia inhibitory factor; TGF-β, transforming growth factor β; TNF, tumor necrosis factor.
Similar articles
-
Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines.
Kirk B, Feehan J, Lombardi G, Duque G. Kirk B, et al. Curr Osteoporos Rep. 2020 Aug;18(4):388-400. doi: 10.1007/s11914-020-00599-y. Curr Osteoporos Rep. 2020. PMID: 32529456 Review.
-
Myokines: The endocrine coupling of skeletal muscle and bone.
Gomarasca M, Banfi G, Lombardi G. Gomarasca M, et al. Adv Clin Chem. 2020;94:155-218. doi: 10.1016/bs.acc.2019.07.010. Epub 2019 Aug 8. Adv Clin Chem. 2020. PMID: 31952571 Review.
-
Pedersen BK. Pedersen BK. J Exp Biol. 2011 Jan 15;214(Pt 2):337-46. doi: 10.1242/jeb.048074. J Exp Biol. 2011. PMID: 21177953
-
Myokines in metabolic homeostasis and diabetes.
Eckel J. Eckel J. Diabetologia. 2019 Sep;62(9):1523-1528. doi: 10.1007/s00125-019-4927-9. Epub 2019 Jul 1. Diabetologia. 2019. PMID: 31263909 Review.
-
Muscles, exercise and obesity: skeletal muscle as a secretory organ.
Pedersen BK, Febbraio MA. Pedersen BK, et al. Nat Rev Endocrinol. 2012 Apr 3;8(8):457-65. doi: 10.1038/nrendo.2012.49. Nat Rev Endocrinol. 2012. PMID: 22473333 Review.
Cited by
-
Exercise as a tool to mitigate metabolic disease.
Esteves JV, Stanford KI. Esteves JV, et al. Am J Physiol Cell Physiol. 2024 Sep 1;327(3):C587-C598. doi: 10.1152/ajpcell.00144.2024. Epub 2024 Jul 9. Am J Physiol Cell Physiol. 2024. PMID: 38981607 Free PMC article. Review.
-
Lin JZ, Ma JD, Yang LJ, Zou YW, Zhang XP, Pan J, Li QH, Li HG, Yang ZH, Wu T, Zhang Q, Mo YQ, Dai L. Lin JZ, et al. Front Immunol. 2022 Oct 18;13:1005161. doi: 10.3389/fimmu.2022.1005161. eCollection 2022. Front Immunol. 2022. PMID: 36330524 Free PMC article.
-
Sheng R, Cao M, Song M, Wang M, Zhang Y, Shi L, Xie T, Li Y, Wang J, Rui Y. Sheng R, et al. J Orthop Translat. 2023 Nov 5;43:36-46. doi: 10.1016/j.jot.2023.09.007. eCollection 2023 Nov. J Orthop Translat. 2023. PMID: 38021216 Free PMC article. Review.
-
Bunn RC, Adatorwovor R, Smith RR, Ray PD, Fields SE, Keeble AR, Fry CS, Uppuganti S, Nyman JS, Fowlkes JL, Kalaitzoglou E. Bunn RC, et al. JBMR Plus. 2023 Oct 26;7(11):e10833. doi: 10.1002/jbm4.10833. eCollection 2023 Nov. JBMR Plus. 2023. PMID: 38025035 Free PMC article.
-
Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases.
Lyu JX, Guo DD, Song YC, Zhang MR, Ge FQ, Zhao J, Zhu H, Hang PZ. Lyu JX, et al. Rev Cardiovasc Med. 2024 Feb 5;25(2):56. doi: 10.31083/j.rcm2502056. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077334 Free PMC article. Review.
References
-
- Kjaer M, Secher NH, Bangsbo J, et al. Hormonal and metabolic responses to electrically induced cycling during epidural anesthesia in humans. J Appl Physiol (1985). 1996;80(6):2156-2162. - PubMed
-
- Mohr T, Andersen JL, Biering-Sørensen F, et al. Long-term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord. 1997;35(1):1-16. - PubMed
-
- Goldstein M. Humoral nature of hypoglycemia in muscular activity. Am J Physiol. 1961;200:67-70.
-
- Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24(2-3):113-119. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous